about
Ullrich scleroatonic muscular dystrophy is caused by recessive mutations in collagen type VIGenome-wide association study of vitamin B6, vitamin B12, folate, and homocysteine blood concentrationsA Case Based Approach to Clinical Genetics of Thoracic Aortic Aneurysm/Dissection.Marfan syndrome: current perspectivesA heterozygous splice site mutation in COL6A1 leading to an in-frame deletion of the alpha1(VI) collagen chain in an italian family affected by bethlem myopathyAltered expression of the MCSP/NG2 chondroitin sulfate proteoglycan in collagen VI deficiencyThe antiangiogenic tissue kallikrein pattern of endothelial cells in systemic sclerosisNdufc2 Gene Inhibition Is Associated With Mitochondrial Dysfunction and Increased Stroke Susceptibility in an Animal Model of Complex Human DiseaseOxidative modification of fibrinogen is associated with altered function and structure in the subacute phase of myocardial infarction.A model of anti-angiogenesis: differential transcriptosome profiling of microvascular endothelial cells from diffuse systemic sclerosis patients.Gene expression profile of rat left ventricles reveals persisting changes following chronic mild exercise protocol: implications for cardioprotection.H3M2: detection of runs of homozygosity from whole-exome sequencing data.Using a calibration experiment to assess gene-specific information: full Bayesian and empirical Bayesian models for two-channel microarray data.Role of C677T and A1298C MTHFR, A2756G MTR and -786 C/T eNOS gene polymorphisms in atrial fibrillation susceptibility.Clopidogrel non-responsiveness and risk of cardiovascular morbidity. An updated meta-analysis.EXCAVATOR: detecting copy number variants from whole-exome sequencing dataWNP: a novel algorithm for gene products annotation from weighted functional networks.Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis.FBN1 mutation screening of patients with Marfan syndrome and related disorders: detection of 46 novel FBN1 mutations.Identification of fibrillin 1 gene mutations in patients with bicuspid aortic valve (BAV) without Marfan syndrome.Inflammatory and antioxidant pattern unbalance in "clopidogrel-resistant" patients during acute coronary syndromeCharacterization and identification of hidden rare variants in the human genome.Unbalanced Metalloproteinase-9 and Tissue Inhibitors of Metalloproteinases Ratios Predict Hemorrhagic Transformation of Lesion in Ischemic Stroke Patients Treated with Thrombolysis: Results from the MAGIC Study.Genetic Contributions to the Development of Complications in Preterm Newborns.Risk and Determinants of Dementia in Patients with Mild Cognitive Impairment and Brain Subcortical Vascular Changes: A Study of Clinical, Neuroimaging, and Biological Markers-The VMCI-Tuscany Study: Rationale, Design, and Methodology.Apolipoprotein(a) Kringle-IV Type 2 Copy Number Variation Is Associated with Venous Thromboembolism.Role of hyperhomocysteinemia in aortic disease.Th1 and Th2 T-helper cells exert opposite regulatory effects on procoagulant activity and tissue factor production by human monocytes.Association between homocysteine, vitamin B(6) concentrations and inflammation.Relation of CYP2C19 loss-of-function polymorphism to the occurrence of stent thrombosis.Cytochrome P450 2C19*2 polymorphism and cardiovascular recurrences in patients taking clopidogrel: a meta-analysis.Antiplatelets in acute coronary syndrome: personal perspectives.Gender and anti-thrombotic therapy: from biology to clinical implications.Stent-related defects in patients presenting with stent thrombosis: differences at optical coherence tomography between subacute and late/very late thrombosis in the Mechanism Of Stent Thrombosis (MOST) study.High residual platelet reactivity after clopidogrel loading and long-term cardiovascular events among patients with acute coronary syndromes undergoing PCI.Carotid artery disease: novel pathophysiological mechanisms identified by gene-expression profiling of peripheral blood.On-treatment platelet reactivity: State of the art and perspectives.Association of rs1466535 LRP1 but not rs3019885 SLC30A8 and rs6674171 TDRD10 gene polymorphisms with abdominal aortic aneurysm in Italian patients.Systemic sclerosis-endothelial cell antiangiogenic pentraxin 3 and matrix metalloprotease 12 control human breast cancer tumor vascularization and development in miceRelation of cytochrome P450 2C19 loss-of-function polymorphism to occurrence of drug-eluting coronary stent thrombosis.
P50
Q24629650-C70C0F4C-8255-4B91-8CD5-C0C6EA6EA76AQ24644637-33495EB6-383D-44C7-9850-46D57589E5F5Q26744537-5A43810B-B41D-45B0-A567-8A51AF777109Q26747739-09CB0B72-3991-4CB2-A4F7-670CFAFFA0C6Q28144096-C21A2E11-B8FC-4461-996B-F91F556C0910Q28272792-A2EE24E5-66CB-4F99-9303-DA7AE0F4DFD2Q28279380-2E721B34-AD6A-4971-A798-A51F71F34A9DQ28578344-53C40CEB-66D5-4164-BE19-67B816CAC539Q30362121-5341B51B-B7C5-484D-B32A-671D8A4C730FQ30478833-EC5B0B23-1603-4590-8332-E9B256207232Q30495607-ACD22A5D-C1B6-45C5-BE2E-429AF89EE014Q30833450-D9E54194-E4FC-4050-A2CA-3027818D5821Q31015408-8E5A4E93-488C-4DC1-B2A0-88920D700F88Q33286816-29D45365-1DF2-4E9D-BD90-36AC80B83B4BQ33529765-EA3DCADC-927A-4319-A0D9-7332A012455FQ33742574-349ED683-5CBA-42B0-A135-DDAB486D5BE3Q34325782-F9973B2C-AA67-4DAA-B34A-4CF7B17DCE84Q34624862-D3B5B5BE-715C-400B-8144-889EEBB84002Q34774069-ED4FA17F-DDFD-4855-A468-4DA785B5D677Q35101523-907A2E09-D105-4417-A7CB-54AFD29E8DA9Q35250401-13A3CF79-2C22-46A1-A9B2-EF2D122719CDQ35559123-59839B64-DC25-4AB3-BAFA-F361575BBEDEQ35652269-5C6F6B99-1C1B-44F9-A525-D661510F4099Q35690660-B480CF1F-6F7D-4BBB-8D90-7C41FE83910EQ35895842-738E4272-9E46-4214-81BE-D00B1FEA1ED7Q35930428-F84AF0D7-AE0F-498D-AA96-BC12ABC1D3B7Q36037038-3767C576-8010-450C-A409-1B428548A1FCQ36709354-EF39F1D5-EA64-4F5C-97C0-ECA0FD5F173DQ36996487-922F7E6D-9112-4C8A-8EB6-965C074EE617Q37693951-F9B0603F-75FB-4482-8227-5C65F40621DFQ37721156-7502FD48-30FE-442E-B8CF-2E2E891C1E23Q38068595-3017A2D2-703B-4124-A222-9B579E0120AAQ38182428-90AAFCDB-2F9E-424D-9738-5E3F7CC5C613Q38438283-A4437CCB-932F-4E3D-A2D3-31D6A47E1BF3Q38484239-17DAC148-63A7-4555-B29C-FF2D12278DF4Q38505361-3DA2A42D-5837-4205-BC0C-910176AACD0CQ38621049-6AD94C9B-E6B6-4162-8DE8-6BB492579A39Q39272661-DC7DEE13-BA39-4FCD-B0E3-D274A7A12AA8Q39793015-6D5DF80F-09A3-405F-AE5F-291B23A05D34Q39996910-00C02389-BC03-4454-85E8-6B7ACB0F606E
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Betti Giusti
@ast
Betti Giusti
@en
Betti Giusti
@es
Betti Giusti
@nl
Betti Giusti
@sl
type
label
Betti Giusti
@ast
Betti Giusti
@en
Betti Giusti
@es
Betti Giusti
@nl
Betti Giusti
@sl
prefLabel
Betti Giusti
@ast
Betti Giusti
@en
Betti Giusti
@es
Betti Giusti
@nl
Betti Giusti
@sl
P1053
K-6978-2016
P106
P1153
7003589237
P21
P2798
P31
P3829
P496
0000-0002-8708-9444